| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant aspirin therapy and colorectal cancer survival
|
Lee, Seohyuk
|
|
|
10 |
3 |
p. 184-185
|
artikel
|
| 2 |
Alcohol and cancer risk: bridging the awareness gap
|
The Lancet Gastroenterology & Hepatology,
|
|
|
10 |
3 |
p. 183
|
artikel
|
| 3 |
Antibiotics versus appendicectomy in acute appendicitis: delay is not denial
|
Adisa, Adewale O
|
|
|
10 |
3 |
p. 187-188
|
artikel
|
| 4 |
Antibiotic treatment versus appendicectomy for acute appendicitis in adults: an individual patient data meta-analysis
|
Scheijmans, Jochem C G
|
|
|
10 |
3 |
p. 222-233
|
artikel
|
| 5 |
Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial
|
Chia, John W K
|
|
|
10 |
3 |
p. 198-209
|
artikel
|
| 6 |
Correction to Lancet Gastroenterol Hepatol 2023; 8: 976–89
|
|
|
|
10 |
3 |
p. e6
|
artikel
|
| 7 |
Hepatitis B treatment in Africa: learning points from a scale-up programme in Ethiopia
|
Desalegn, Hailemichael
|
|
|
10 |
3 |
p. 190-192
|
artikel
|
| 8 |
Inflammatory bowel disease in south Asia: a scoping review
|
Shenoy, Shabari
|
|
|
10 |
3 |
p. 259-274
|
artikel
|
| 9 |
Long-term VEDOKIDS results: implications for practice and research
|
Spencer, Elizabeth A
|
|
|
10 |
3 |
p. 189-190
|
artikel
|
| 10 |
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study
|
Atia, Ohad
|
|
|
10 |
3 |
p. 234-247
|
artikel
|
| 11 |
No easy way out: blocking lymphocyte egress by the S1P1 receptor 1 modulator tamuzimod in ulcerative colitis
|
Atreya, Raja
|
|
|
10 |
3 |
p. 185-187
|
artikel
|
| 12 |
Research in Brief
|
Baker, Holly
|
|
|
10 |
3 |
p. 196
|
artikel
|
| 13 |
Tamuzimod in patients with moderately-to-severely active ulcerative colitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 induction trial
|
Sands, Bruce E
|
|
|
10 |
3 |
p. 210-221
|
artikel
|
| 14 |
Thank you to The Lancet Gastroenterology & Hepatology's statistical and peer reviewers in 2024
|
The Lancet Gastroenterology & Hepatology's Editors,
|
|
|
10 |
3 |
p. e2-e5
|
artikel
|
| 15 |
The hitchhiker's guide to the gut
|
McQuillan, Cahal
|
|
|
10 |
3 |
p. 197
|
artikel
|
| 16 |
The liver–brain axis in metabolic dysfunction-associated steatotic liver disease
|
Mikkelsen, Anne Catrine Daugaard
|
|
|
10 |
3 |
p. 248-258
|
artikel
|
| 17 |
Vedolizumab for prevention of recurrence of Crohn's disease
|
Nguyen, Andrew
|
|
|
10 |
3 |
p. 193-194
|
artikel
|
| 18 |
Vedolizumab for prevention of recurrence of Crohn's disease
|
Hammoudi, Nassim
|
|
|
10 |
3 |
p. 193
|
artikel
|
| 19 |
Vedolizumab for prevention of recurrence of Crohn's disease – Authors' reply
|
D'Haens, Geert
|
|
|
10 |
3 |
p. 194-195
|
artikel
|
Tijdschrift beschrijving